Valeur202020212022202320242025Total du passif35.11 M35.05 M58.57 M38.38 M34.34 M18.04 MTotal des capitaux propres101.97 M169.44 M136.85 M106.02 M97.37 M76.58 MTotal du passif et des capitaux propres137.08 M204.49 M195.42 M144.4 M131.71 M94.62 MDette totale——————Dette nette——————
Arbutus Biopharma Corporation - Common Stock
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.